Developer docs
API playgroundTry for free, no card

Search company profiles

eticur

Full company profile

uuid0024tut

Namestring
eticur
Legal namestring
FamiCord AG
Websiteurl
eticur.de
Company typeenum
Private
Founded yearint
2004
Descriptiontext

eticur is a German consumer cord blood and cord tissue stem cell banking service, organized as the national retail brand of FamiCord AG (part of the FamiCord Capital Group, described as Europe's leading stem cell bank). The company offers expectant parents the collection, processing, cryopreservation, and long-term storage of stem cells derived from umbilical cord blood (hematopoietic stem cells) and umbilical cord tissue (mesenchymal stem cells). Operations are anchored by a GMP-certified laboratory within the FamiCord Group, operating under German Medicines Act (AMG) manufacturing authorizations — §13 AMG for cord blood, and §20b and §20c AMG for cord tissue collection and storage. Collection is performed by a Germany-wide network of cooperating licensed childbirth facilities and affiliated obstetricians and midwives under FamiCord's manufacturing authorization.

The business is direct-to-consumer, targeting German expectant parents acquired through a multi-channel marketing mix: website content (eti.verse), Google Ads, Meta (Facebook/Instagram) advertising, YouTube, a 14-day email education course, a referral program (Eltern-werben-Eltern), and healthcare-professional referrals from gynecologists, midwives, and hospitals. Customers self-serve through an online configurator (konfigurator.eticur.de) that includes a clinic finder across the partner network, with sales support provided via a German-language hotline and email.

eticur generates revenue primarily through subscription storage contracts offered in three variants: Vorauszahlung (prepaid multi-year), Jahresabo (annual subscription from child's first birthday), and Monatsabo (monthly subscription from birth), each with a minimum two-year term and CPI-linked price adjustments. Additional monetization includes one-time start fees, optional quality testing, transport services, and replacement collection kits (eti.box). Revenue is structurally recurring once a sample is banked, with optional multi-child discounts under the prepaid plan and a €150 bilateral referral incentive. The legal entity is FamiCord AG, registered in Leipzig, Germany, with group leadership spanning CEO Jakub Baran, CFO Thomas Pfaadt, CMO Tomasz Baran, CCO Dr. Conelia Wittke-Kothe, and Supervisory Board Chairman Dr. Peter Greiner.

Short descriptiontext

eticur is a German consumer cord blood and cord tissue stem cell banking brand operated by FamiCord AG, offering collection, cryopreservation, and long-term storage to expectant parents through a Germany-wide network of cooperating hospitals and a direct online configurator.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMünchen, Germany
HQ citystring
München
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cord blood banking, stem cell storage, cord tissue preservation, cryopreservation services, biological health insurance
Industry3 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAMAE
Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLALABAG
Biologics, Vaccines & Ultra-Low Temperature (ULT) Storage
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Stem Cell Banking
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Cord Blood and Cord Tissue Banking — Subscription Model
TypeSubscription Recurring
Description

eticur generates revenue primarily through recurring subscription fees paid by families for the collection, processing, cryopreservation, and long-term storage of cord blood and/or cord tissue stem cells. Three contract variants are offered: (1) Vorauszahlung (prepaid) — a one-time upfront payment covering an initial period plus annual storage fees thereafter; (2) Jahresabo (annual subscription) — a one-time start fee plus annual recurring fees starting from the child's first birthday; (3) Monatsabo (monthly subscription) — monthly fees starting from the date of birth. All contract variants have a minimum term of two years. The company also charges for optional services such as quality testing, transport of biological material to treatment centers, and replacement collection kits.

nabelschnurblut.eticur.de
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details3 tiers
1Vorauszahlung (Prepaid) — one-time upfront payment covering an initial period plus annual storage fees
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One-time upfront payment for the prepayment period, plus annual storage fees thereafter. Multi-child discounts available under this variant.

nabelschnurblut.eticur.de
2Jahresabo (Annual Subscription) — start fee plus annual recurring fees from child's first birthday
ModelSubscriptionBilling cadenceAnnual
Notes

One-time start fee plus annual recurring fees starting from child's first birthday. Minimum term of two years.

nabelschnurblut.eticur.de
3Monatsabo (Monthly Subscription) — monthly fees from date of birth
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly recurring fees starting from the date of birth. Minimum term of two years.

nabelschnurblut.eticur.de
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

eticur organizes the collection, processing, cryopreservation, and long-term storage of stem cells from umbilical cord blood and cord tissue for expectant parents in Germany. The biological material is collected at cooperating hospitals and birthing centers, then processed and stored in a GMP-certified laboratory operated within the FamiCord Group. Customers contract for storage services on prepaid, annual subscription, or monthly subscription plans with a minimum term of two years.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Over 80 diseases treatable with cord blood stem cells
Product overview1 text field

eticur is a cord blood and cord tissue stem cell banking service operated by FamiCord AG. The company offers collection, processing, cryopreservation, and long-term storage of umbilical cord blood and cord tissue through a network of partner clinics across Germany. Customers can store cord blood (containing blood stem cells for treating blood diseases, immune deficiencies, and neurological disorders) and/or cord tissue (containing stem cells for cartilage, bone, muscle, and nerve cells). The service is available through three pricing plans: prepayment (one-time upfront payment), annual subscription, or monthly subscription. Additional offerings include the eti.box collection kit and the eti.verse educational content platform featuring pregnancy guides and a week-by-week pregnancy calendar.

Product and service3 records
1Nabelschnurblut (Cord Blood Banking)
CategoryCore service
Description

Umbilical cord blood collection, processing, cryopreservation, and long-term storage service for expectant parents. Contains blood stem cells (hematopoietic stem cells) that can regenerate all human blood cells and are used in treatments for blood diseases, immune deficiencies, and neurological disorders.

2Nabelschnurgewebe (Cord Tissue Banking)
CategoryCore service
Description

Umbilical cord tissue collection and storage service for expectant parents. Contains mesenchymal stem cells capable of forming cartilage, bone, muscle, and nerve cells, currently researched for treatment of widespread conditions such as osteoarthritis.

3eti.box (Collection Kit)
CategoryPhysical product
Description

Physical collection kit (Entnahmekit) provided to parents prior to delivery, containing the necessary materials and instructions for umbilical cord blood and tissue collection at partner clinics.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthers
Description

eticur is the consumer brand operated by FamiCord AG, a European stem cell banking group. FamiCord provides the GMP-certified laboratory infrastructure, regulatory authorizations (§ 13, § 20b, § 20c AMG), and corporate governance including board leadership (CEO Jakub Baran, CFO Thomas Pfaadt, CMO Tomasz Baran, CCO Dr. Conelia Wittke-Kothe). The group is described as Europe's leading stem cell bank.

2Cooperating Childbirth Facilities (Germany-wide network)
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

eticur maintains contracts with a Germany-wide network of licensed childbirth facilities (Kooperierende Entbindungseinrichtungen) that perform the cord blood and cord tissue collection under FamiCord's manufacturing authorization. These facilities and their affiliated obstetricians and midwives are trained and contractually bound to eticur's collection protocols. The homepage references a clinic finder (Klinik-Netzwerk) listing all partner facilities.

nabelschnurblut.eticur.de
Strategic tierMinorTypeGTM or Marketing Partner
Description

eticur sends post-invoice customer satisfaction survey invitations through Trustpilot (Trustpilot A/S, Copenhagen, Denmark). Reviews are published on Trustpilot's platform. The company shares customer email addresses, names, and internal booking numbers with Trustpilot for this purpose.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

eticur

Stem Cell Bankingeticur.de

eticur is a German consumer cord blood and cord tissue stem cell banking brand operated by FamiCord AG, offering collection, cryopreservation, and long-term storage to expectant parents through a Germany-wide network of cooperating hospitals and a direct online configurator.

What eticur does

eticur is a German consumer cord blood and cord tissue stem cell banking service, organized as the national retail brand of FamiCord AG (part of the FamiCord Capital Group, described as Europe's leading stem cell bank). The company offers expectant parents the collection, processing, cryopreservation, and long-term storage of stem cells derived from umbilical cord blood (hematopoietic stem cells) and umbilical cord tissue (mesenchymal stem cells). Operations are anchored by a GMP-certified laboratory within the FamiCord Group, operating under German Medicines Act (AMG) manufacturing authorizations — §13 AMG for cord blood, and §20b and §20c AMG for cord tissue collection and storage. Collection is performed by a Germany-wide network of cooperating licensed childbirth facilities and affiliated obstetricians and midwives under FamiCord's manufacturing authorization.

The business is direct-to-consumer, targeting German expectant parents acquired through a multi-channel marketing mix: website content (eti.verse), Google Ads, Meta (Facebook/Instagram) advertising, YouTube, a 14-day email education course, a referral program (Eltern-werben-Eltern), and healthcare-professional referrals from gynecologists, midwives, and hospitals. Customers self-serve through an online configurator (konfigurator.eticur.de) that includes a clinic finder across the partner network, with sales support provided via a German-language hotline and email.

eticur generates revenue primarily through subscription storage contracts offered in three variants: Vorauszahlung (prepaid multi-year), Jahresabo (annual subscription from child's first birthday), and Monatsabo (monthly subscription from birth), each with a minimum two-year term and CPI-linked price adjustments. Additional monetization includes one-time start fees, optional quality testing, transport services, and replacement collection kits (eti.box). Revenue is structurally recurring once a sample is banked, with optional multi-child discounts under the prepaid plan and a €150 bilateral referral incentive. The legal entity is FamiCord AG, registered in Leipzig, Germany, with group leadership spanning CEO Jakub Baran, CFO Thomas Pfaadt, CMO Tomasz Baran, CCO Dr. Conelia Wittke-Kothe, and Supervisory Board Chairman Dr. Peter Greiner.

eticur firmographics

Firmographics
Name
eticur
Legal name
FamiCord AG
Website
https://eticur.de
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1–10 employees
Short description
eticur is a German consumer cord blood and cord tissue stem cell banking brand operated by FamiCord AG, offering collection, cryopreservation, and long-term storage to expectant parents through a Germany-wide network of cooperating hospitals and a direct online configurator.
Ownership category
akta.pro rank

eticur industry classification

Industry
Product category
Stem Cell Banking
NAICS
Blood and Organ Banks (621991)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAMAE
Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLALABAG
Biologics, Vaccines & Ultra-Low Temperature (ULT) Storage

Keywords

  • Cord blood banking
  • Stem cell storage
  • Cord tissue preservation
  • Cryopreservation services
  • Biological health insurance

Where eticur is headquartered

Location

Headquarters

HQ city
München
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

eticur business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Cord Blood and Cord Tissue Banking — Subscription Model: eticur generates revenue primarily through recurring subscription fees paid by families for the collection, processing, cryopreservation, and long-term storage of cord blood and/or cord tissue stem cells. Three contract variants are offered: (1) Vorauszahlung (prepaid) — a one-time upfront payment covering an initial period plus annual storage fees thereafter; (2) Jahresabo (annual subscription) — a one-time start fee plus annual recurring fees starting from the child's first birthday; (3) Monatsabo (monthly subscription) — monthly fees starting from the date of birth. All contract variants have a minimum term of two years. The company also charges for optional services such as quality testing, transport of biological material to treatment centers, and replacement collection kits.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractVorauszahlung (Prepaid) — one-time upfront payment covering an initial period plus annual storage fees
SubscriptionAnnualJahresabo (Annual Subscription) — start fee plus annual recurring fees from child's first birthday
SubscriptionMonthlyMonatsabo (Monthly Subscription) — monthly fees from date of birth

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

eticur product offering

Product offering

Core offering

eticur organizes the collection, processing, cryopreservation, and long-term storage of stem cells from umbilical cord blood and cord tissue for expectant parents in Germany. The biological material is collected at cooperating hospitals and birthing centers, then processed and stored in a GMP-certified laboratory operated within the FamiCord Group. Customers contract for storage services on prepaid, annual subscription, or monthly subscription plans with a minimum term of two years.

Product overview

eticur is a cord blood and cord tissue stem cell banking service operated by FamiCord AG. The company offers collection, processing, cryopreservation, and long-term storage of umbilical cord blood and cord tissue through a network of partner clinics across Germany. Customers can store cord blood (containing blood stem cells for treating blood diseases, immune deficiencies, and neurological disorders) and/or cord tissue (containing stem cells for cartilage, bone, muscle, and nerve cells). The service is available through three pricing plans: prepayment (one-time upfront payment), annual subscription, or monthly subscription. Additional offerings include the eti.box collection kit and the eti.verse educational content platform featuring pregnancy guides and a week-by-week pregnancy calendar.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nabelschnurblut (Cord Blood Banking) Umbilical cord blood collection, processing, cryopreservation, and long-term storage service for expectant parents. Contains blood stem cells (hematopoietic stem cells) that can regenerate all human blood cells and are used in treatments for blood diseases, immune deficiencies, and neurological disorders.
  • Nabelschnurgewebe (Cord Tissue Banking) Umbilical cord tissue collection and storage service for expectant parents. Contains mesenchymal stem cells capable of forming cartilage, bone, muscle, and nerve cells, currently researched for treatment of widespread conditions such as osteoarthritis.
  • eti.box (Collection Kit) Physical collection kit (Entnahmekit) provided to parents prior to delivery, containing the necessary materials and instructions for umbilical cord blood and tissue collection at partner clinics.

Quantifiable outcome

  • Over 80 diseases treatable with cord blood stem cells

Companies that use eticur

Customer profile

Segments1 record

Ideal customer profiles1 record

eticur technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

eticur partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • FamiCord AG (Parent Company)coreOtherseticur is the consumer brand operated by FamiCord AG, a European stem cell banking group. FamiCord provides the GMP-certified laboratory infrastructure, regulatory authorizations (§ 13, § 20b, § 20c AMG), and corporate governance including board leadership (CEO Jakub Baran, CFO Thomas Pfaadt, CMO Tomasz Baran, CCO Dr. Conelia Wittke-Kothe). The group is described as Europe's leading stem cell bank.
  • Cooperating Childbirth Facilities (Germany-wide network)coreImplementation/ SI/ Consulting Partnereticur maintains contracts with a Germany-wide network of licensed childbirth facilities (Kooperierende Entbindungseinrichtungen) that perform the cord blood and cord tissue collection under FamiCord's manufacturing authorization. These facilities and their affiliated obstetricians and midwives are trained and contractually bound to eticur's collection protocols. The homepage references a clinic finder (Klinik-Netzwerk) listing all partner facilities.
  • TrustpilotminorGTM or Marketing Partnereticur sends post-invoice customer satisfaction survey invitations through Trustpilot (Trustpilot A/S, Copenhagen, Denmark). Reviews are published on Trustpilot's platform. The company shares customer email addresses, names, and internal booking numbers with Trustpilot for this purpose.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

eticur competitors and assessment

Company assessment

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

eticur social profiles

Digital presence

eticur compliance and trust

Trust signal

Compliance5 records

eticur financial estimates

Financial estimate

Revenue estimate

Valuation estimate

eticur leadership team

Management profile

Number of profiles

Profiles6 records

eticur funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

eticur M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eticur

What does eticur do?

eticur organizes the collection, processing, cryopreservation, and long-term storage of stem cells from umbilical cord blood and cord tissue for expectant parents in Germany. The biological material is collected at cooperating hospitals and birthing centers, then processed and stored in a GMP-certified laboratory operated within the FamiCord Group. Customers contract for storage services on prepaid, annual subscription, or monthly subscription plans with a minimum term of two years.

Is eticur a public or private company?

eticur is a private company. It is classified as corporate owned and is currently operating.

When was eticur founded?

eticur was founded in 2004. It employs 1 to 10 people.

Where is eticur based?

eticur is headquartered in München, Germany, in the Europe region.

How does eticur make money?

One revenue line is on record: cord Blood and Cord Tissue Banking — Subscription Model.

Does eticur have an API?

No public API is recorded for eticur.

What industry is eticur in?

eticur's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAMAE, Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics. Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales